These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28135602)

  • 21. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
    Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
    Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.
    Malisic E; Susnjar S; Milovanovic J; Todorovic-Rakovic N; Kesic V
    Arch Gynecol Obstet; 2018 Feb; 297(2):495-503. PubMed ID: 29101609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
    Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A
    Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve.
    Iwase A; Osuka S; Nakamura T; Kato N; Takikawa S; Goto M; Kikkawa F
    Reprod Sci; 2016 Jun; 23(6):756-60. PubMed ID: 26614267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women.
    Dunlop CE; Anderson RA
    Maturitas; 2015 Mar; 80(3):245-50. PubMed ID: 25596814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer.
    Anderson RA; Kelsey TW; Perdrix A; Olympios N; Duhamel O; Lambertini M; Clatot F
    Breast Cancer Res Treat; 2022 Apr; 192(2):273-282. PubMed ID: 34997365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of serum Anti-Müllerian Hormone (AMH) level in young women treated with chemotherapy for breast cancer according to basal AMH level.
    Loubersac S; Dezellus A; Lefebvre T; Reignier A; Barriere P; Masson D; Freour T;
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():132-137. PubMed ID: 32971432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
    Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
    Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.
    Ben-Aharon I; Meizner I; Granot T; Uri S; Hasky N; Rizel S; Yerushalmi R; Sulkes A; Stemmer SM
    Oncologist; 2012; 17(11):1386-93. PubMed ID: 22956534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study.
    Brougham MF; Crofton PM; Johnson EJ; Evans N; Anderson RA; Wallace WH
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2059-67. PubMed ID: 22472563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of breast cancer on anti-mullerian hormone levels in young women.
    Su HI; Flatt SW; Natarajan L; DeMichele A; Steiner AZ
    Breast Cancer Res Treat; 2013 Jan; 137(2):571-7. PubMed ID: 23224236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of postchemotherapy ovarian function using markers of ovarian reserve.
    Henry NL; Xia R; Schott AF; McConnell D; Banerjee M; Hayes DF
    Oncologist; 2014 Jan; 19(1):68-74. PubMed ID: 24319018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Ovarian Reserve Screening with Anti-Müllerian Hormone for Reproductive Age Women Deferring Pregnancy.
    Grossman LC; Safier LZ; Kline MD; Chan CW; Lobo RA; Sauer MV; Douglas NC
    J Womens Health (Larchmt); 2017 Apr; 26(4):345-351. PubMed ID: 27906603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.
    Chai J; Howie AF; Cameron DA; Anderson RA
    Eur J Cancer; 2014 Sep; 50(14):2367-74. PubMed ID: 25027307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer.
    Torino F; Barnabei A; De Vecchis L; Sini V; Schittulli F; Marchetti P; Corsello SM
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):27-42. PubMed ID: 23953684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer.
    Goldfarb SB; Turan V; Bedoschi G; Taylan E; Abdo N; Cigler T; Bang H; Patil S; Dickler MN; Oktay KH
    Breast Cancer Res Treat; 2021 Jan; 185(1):165-173. PubMed ID: 32930927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
    Nelson SM; Davis SR; Kalantaridou S; Lumsden MA; Panay N; Anderson RA
    Hum Reprod Update; 2023 May; 29(3):327-346. PubMed ID: 36651193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.